ConductScience.org, home

Paper3333882

The metabolism and biopharmaceutics of spironolactone in man.

Overdiek HW and 1 other. Rev Drug Metab Drug Interact, 1987. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. The metabolism and biopharmaceutics of spironolactone in man. Papers, record 3333882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3333882

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The metabolism and biopharmaceutics of spironolactone in man.
PubMed
Journal
Rev Drug Metab Drug Interact
PubMed
Year
1987
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2019-10-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Overdiek HWH W
2Merkus FWF W

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SpironolactoneMajor topic
Aged
Biological Availability
Biotransformation
Humans

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
41282597Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review.Front Pharmacol2025https://conductscience.org/library/papers/41282597PubMed
40143132Model-Informed Dose Optimization of Spironolactone in Neonates and Infants.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40143132PubMed
37647894Approach to the Patient: Reninoma.J Clin Endocrinol Metab2024https://conductscience.org/library/papers/37647894PubMed
37439256Biomarkers to Guide Medical Therapy in Primary Aldosteronism.Endocr Rev2024https://conductscience.org/library/papers/37439256PubMed
37261664Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.Clin Pharmacokinet2023https://conductscience.org/library/papers/37261664PubMed
37137720METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl S-Thiol Methyl Transferase Activity in Liver.Drug Metab Dispos2023https://conductscience.org/library/papers/37137720PubMed
36744253Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone.Front Pharmacol2023https://conductscience.org/library/papers/36744253PubMed
34668529Pannexin 1: a novel regulator of acute hypoxic pulmonary vasoconstriction.Cardiovasc Res2022https://conductscience.org/library/papers/34668529PubMed
29798905Response by Good et al to Letter Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone".Circ Res2018https://conductscience.org/library/papers/29798905PubMed
2863426830 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development.J Endocrinol2017https://conductscience.org/library/papers/28634268PubMed
25473283Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.Int J Nanomedicine2014https://conductscience.org/library/papers/25473283PubMed
18078011Aldosterone antagonism in heart failure.Vasc Health Risk Manag2007https://conductscience.org/library/papers/18078011PubMed
15257869Aldosterone-receptor antagonism and end-stage renal disease.Curr Hypertens Rep2004https://conductscience.org/library/papers/15257869PubMed
14669838Aldosterone receptor antagonists: biology and novel therapeutical applications.J Endocrinol Invest2003https://conductscience.org/library/papers/14669838PubMed
12974768Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.Clin Exp Immunol2003https://conductscience.org/library/papers/12974768PubMed
8144871Hirsutism and the effectiveness of spironolactone in its management.J Endocrinol Invest1993https://conductscience.org/library/papers/8144871PubMed
1884726Improved bioavailability from a spironolactone beta-cyclodextrin complex.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1884726PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3333882

GET https://conductscience.org/api/papers/v1/3333882/authors